Device (study) | Population | General accuracy (n) | Accuracy in hypoglycaemia (n) |
---|---|---|---|
Dexcom G6 (Castorino, 2020) [40] | 32 pregnant participants with T1DM, T2M, GDM | Overall MARD 10.3% (734) | 54–69 mg/dl MAD 6.9 mg/dl 79.2% in %15/15 (24) 40–53 mg/dl MAD 7.9 mg/dl 100% in %15/15 (8) |
Dexcom G6 (Welsh, 2019) [41] | 49 participants with T1DM | Overall MARD 7.7% (1387) | < 70 mg/dl MARD 13.3% MAD 9.1 mg/dl 81.5% in %15/15 (81) |
Dexcom G6 (Shah, 2018) [42] | Reprocessed data of 76 participants with T1DM and T2DM | Overall MARD 9.0% (3532) | < 70 mg/dl MARD 9.5% 80% in %15/15 (185) |
Free Style Libre 2 (Alva, 2020) [38] | 273 participants with T1DM and T2DM | Overall MARD 9.2% (adults), 9.7% (children) (25510) | < 70 mg/dl Adults: 94.3% in %15/15 (3473) 89.3% true detection rate, 86% true alarm rate Children: 96.1% in %15/15 (882) |
Eversense and Freestyle Libre (Fokkert, 2020) [43] | 23 participants with T1DM | Eversense: MARD 17% (exercise), 13% (normal daily activity) Freestyle Libre: MARD 20% (exercise), 12% (normal daily activity) (1722) | < 70 mg/dl Eversense: > 85% within ±15 mg/dl 72% (exercise) 76% (normal daily activity) Freestyle Libre: > 85% within ±15 mg/dl 61% (exercise) 78% (normal daily activity) |